Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Meseguer ES"'
Autor:
Meseguer ES; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, 28046 Madrid, Spain., Elizalde MU; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, 28046 Madrid, Spain., Borobia AM; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, 28046 Madrid, Spain., Ramírez E; Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, 28046 Madrid, Spain.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2021 Mar 10; Vol. 10 (6). Date of Electronic Publication: 2021 Mar 10.
Autor:
García IG; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Rodriguez-Rubio M; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Pediatric Intensive Care Department, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain., Mariblanca AR; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., de Soto LM; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., García LD; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Villatoro JM; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Parada JQ; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Meseguer ES; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Rosales MJ; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain., González J; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Internal Medicine Department, Infectious Diseases Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain., Arribas JR; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Internal Medicine Department, Infectious Diseases Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain., Carcas AJ; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., de la Oliva P; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. pedro.oliva@salud.madrid.org.; Pediatric Intensive Care Department, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain. pedro.oliva@salud.madrid.org., Borobia AM; Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain. alberto.borobia@salud.madrid.org.; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. alberto.borobia@salud.madrid.org.
Publikováno v:
Trials [Trials] 2020 Jun 03; Vol. 21 (1), pp. 466. Date of Electronic Publication: 2020 Jun 03.